Skip to main content
AmigoFish

Ben Bikman

Ben BikmanVideo

Format:
YouTube channel
New videos:
Weekly
Typical length:
about 25 minutes
Latest video:
Not rated yet

About this show

For years, as a scientist, my research has focused on the foundational role of metabolic health in controlling body weight and reducing the risk of chronic disease. Understanding how the interaction of calories and hormones affects our metabolic health has become the cornerstone of my work.

I’ve had the privilege of sharing this message with people across the globe, helping them understand the profound impact of their metabolic health on their lives. As a scientist I’m driven to uncover the science behind better health, to make that science accessible to everyone, and help other professionals do the same thing.

If you want to stay connected to the latest in metabolic science and health, I invite you to become an “Insider” at whatever level of participation works for you. You’ll gain access to exclusive research, insights and more.

I look forward to being better connected with you: BenBikman.com

Covers: metabolic health, nutrition science, insulin resistance, weight loss, hormones, glp-1 medications, blood sugar, diet and obesity

Videos come from the channel's public YouTube feed. The artwork is the newest video thumbnail. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent videos, drawn from the publisher's feed.

This video channel, run by scientist Ben Bikman, explores how metabolic health, calories and hormones shape body weight and chronic disease risk. Recent videos cover fat tissue and hunger, GLP-1 medications and diet, potassium and blood sugar, regaining lost weight, and what glucose monitors miss.

Report a problem with this summary

Cosmos

Rated alike

Similar in subject

See the full Cosmos

Videos

  • 149: The Hidden Signals That Make Fat Cells Grow

    · 30 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Nuclear receptors inside fat cells respond to lipid-soluble signals and help determine whether cells become fat cells and how they store energy. Although drugs, dietary fats, cortisol, and environmental chemicals can influence these receptors, insulin remains the dominant upstream signal controlling fat-cell growth and storage. Summary: Dr. Ben Bikman explains how nuclear receptors influence fat cell development, fat storage, and metabolic health. Nuclear receptors are proteins inside the cell nucleus that respond to small lipid-soluble signals—such as fatty acids, bile acids, thyroid hormone, cortisol, and steroid hormones—and translate those signals into changes in gene expression. In fat cells, these receptors help determine whether a precursor cell becomes a fat cell and how that fat cell behaves once it exists. The main focus is PPAR gamma, the master regulator of adipogenesis, or the formation of new fat cells. Ben emphasizes that insulin sits upstream of this entire process: insulin drives PPAR gamma expression and orchestrates the fat-cell-building program. The lecture then connects this biology to diabetes drugs known as TZDs, which activate PPAR gamma to improve insulin sensitivity by creating more small, functional fat cells. While this can improve blood glucose control and raise adiponectin, it often causes fat gain. Ben also discusses how dietary fatty acids can modestly influence PPAR gamma activity and how cortisol, acting through the glucocorticoid receptor, can promote visceral fat accumulation. The practical takeaway is that while we cannot avoid every chemical signal that touches these receptors, we can control the dominant upstream hormonal signal: insulin. Keeping insulin low and stable through carbohydrate control remains the most practical strategy for keeping fat-cell nuclear receptor signaling in a healthier state. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:07 — Introduction: Nuclear Receptors and Fat Cells 01:05 — Fat Cells Are Not Passive Containers 02:06 — What Nuclear Receptors Are 03:06 — How Nuclear Receptors Turn Genes On and Off 04:07 — RXR and the PPAR Family 06:14 — PPAR Gamma: The Master Regulator of Fat Cells 07:49 — How PPAR Gamma Builds the Fat Cell Program 10:09 — Why Insulin Sits Upstream of PPAR Gamma 11:07 — TZD Drugs and PPAR Gamma Activation 13:13 — Why TZDs Improve Glucose but Increase Fat Mass 15:14 — Dietary Fatty Acids as PPAR Gamma Signals 18:42 — Why Dietary Fat Alone Does Not Drive Fat Storage 21:46 — Cortisol, the Glucocorticoid Receptor, and Visceral Fat 25:00 — Obesogens: Environmental Chemicals That Affect Fat Cells 27:15 — Insulin as the Dominant Signal in Fat Accumulation NOTE: The information presented is not intended to be a…

    Not rated yet
  • 148: Why Neuropathy Isn’t Just About Blood Sugar

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Peripheral neuropathy is not caused by high glucose alone, but by the combined effects of hyperglycemia, insulin resistance, and glycemic variability. Protecting nerves requires improving insulin sensitivity and reducing glucose swings—not just lowering A1C. Summary: Dr. Bikman explains why peripheral neuropathy is not simply a “high blood sugar” problem. While hyperglycemia clearly damages nerves, the story is more complex—especially in type 2 diabetes, where intensive glucose control does not prevent neuropathy nearly as well as it does in type 1 diabetes. Dr. Bikman argues that neuropathy is driven by three interacting metabolic forces: chronic hyperglycemia, insulin resistance, and glycemic variability. He begins by defining peripheral neuropathy as damage to the nerves outside the brain and spinal cord, most commonly appearing first in the feet and toes because the longest nerves are often affected earliest. He then explains how excess glucose damages nerves through the sorbitol pathway, oxidative stress, glycation, and inflammation. But glucose is only one part of the problem. The second pillar is insulin resistance. Peripheral nerves and their support cells, especially Schwann cells, need insulin signaling to maintain healthy myelin and nerve repair. When insulin signaling fails, nerves lose an important trophic support system even before glucose becomes severely elevated. The third pillar is glycemic variability, or repeated glucose swings, which may damage nerves beyond what A1C alone can reveal. The key takeaway is that protecting nerves requires more than lowering average blood sugar. It requires improving insulin sensitivity, reducing glucose swings, stabilizing post-meal responses, and addressing the metabolic dysfunction that damages nerves from multiple directions. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:04 — Introduction: Rethinking Neuropathy 02:05 — The Three Metabolic Drivers of Nerve Damage 03:12 — What Peripheral Neuropathy Is 04:23 — How Neuropathy Is Detected 05:19 — Neuropathy Before Diabetes 06:30 — Hyperglycemia and the Sorbitol Pathway 08:40 — Oxidative Stress and Antioxidant Depletion 09:46 — Glycation, AGEs, and Inflammation 11:54 — Insulin Resistance as a Driver of Neuropathy 14:17 — Why Schwann Cells Need Insulin Signaling 16:23 — Glycemic Variability and Nerve Damage 19:50 — Why Time in Range May Matter More Than A1C 21:48 — Practical Strategies for Nerve Protection NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical…

    Not rated yet
  • 147: How Your Brain Talks to Your Pancreas (The Vagus Nerve Explained)

    · 28 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: The vagus nerve is a major communication line between the brain and abdominal organs, helping regulate liver glucose output, gut-brain signaling, and pancreatic insulin secretion. When this neural system is disrupted—by obesity, inflammation, surgery, or altered autonomic balance—nutrient handling and metabolic control can suffer. Summary: Dr. Bikman explores the vagus nerve and its role in nutrient handling, with special attention to the pancreas and insulin secretion. The vagus is the major neural pathway connecting the brain to the metabolic organs of the abdomen, including the gut, pancreas, and liver. Rather than acting only as a motor nerve, it is predominantly sensory, constantly relaying information from the viscera back to the brain while also carrying signals downward that shape digestion, glucose regulation, and hormone release. He explains how the vagus helps regulate liver glucose output, gut-brain communication, and pancreatic beta cell function. He highlights the cephalic phase insulin response, the small early release of insulin triggered by seeing, smelling, tasting, or anticipating food before blood glucose even rises. While this effect is more clearly established in animals than in humans, the evidence suggests it may play a meaningful role in normal meal handling and may be impaired in obesity and metabolic disease. The lecture also examines what happens when the vagus is altered surgically or electrically. Cutting or blocking the vagus can reduce insulin responses to oral glucose and meaningfully affect body weight and glycemic control, while stimulating it through external devices may influence autonomic tone and possibly metabolism. The larger takeaway is that the vagus nerve is not peripheral to metabolism—it is a central regulator of how the brain and abdominal organs coordinate nutrient handling. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:42 — Introduction: The Vagus Nerve and Metabolism 01:53 — Vagus Anatomy: Sensory vs Motor Signaling 04:02 — The Main Abdominal Branches of the Vagus 05:09 — How the Vagus Helps Control Liver Glucose Output 07:38 — Gut-Brain Signaling Through the Vagus 08:48 — How the Vagus Influences the Pancreas and Insulin 10:01 — The Cephalic Phase Insulin Response 13:22 — Why This Early Insulin Signal May Matter Metabolically 15:49 — GLP-1, the Vagus, and Pancreatic Feedback to the Brain 16:52 — How Obesity and Diabetes Disrupt the Vagus-Pancreas Axis 20:11 — What Happens When the Vagus Is Cut or Blocked 23:47 — Vagus Stimulation Devices and Metabolic Effects 27:19 — Final Takeaways: The Neural Control of Nutrient Handling NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or…

    Not rated yet
  • 146: The Muscle Biology Behind Diabetes Risk

    · 35 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Muscle is the body’s main site of insulin-stimulated glucose disposal, but different muscle fiber types handle glucose differently, with slow-twitch type 1 fibers generally supporting better insulin sensitivity. Even so, the most important factor is not just fiber type, but total muscle mass—making exercise, especially resistance training, a powerful tool for protecting metabolic health. Summary: In this lecture, Dr. Ben Bikman explores how skeletal muscle fiber type influences insulin sensitivity and diabetes risk. While muscle is the body’s largest site of insulin-stimulated glucose disposal, not all muscle behaves the same. Different fiber types carry different amounts of the molecular machinery needed to respond to insulin, take up glucose, store it, and burn it. He begins by distinguishing the two major muscle fiber types: type 1 slow-twitch and type 2 fast-twitch. Type 1 fibers are more oxidative, with greater mitochondrial density, while type 2 fibers are more glycolytic and fatigue more quickly. Importantly, type 1 fibers contain more insulin receptors, GLUT4 transporters, and key enzymes involved in glucose handling, helping explain why a higher proportion of these fibers is associated with better insulin sensitivity. Dr. Bikman then connects these differences to real-world metabolic risk. Studies show that individuals with fewer type 1 fibers can have significantly lower insulin sensitivity—even when they appear healthy by standard markers. He also explores how these patterns may contribute to ethnic differences in diabetes risk across populations. The key takeaway is that fiber type is not destiny. While genetics plays a role, exercise can improve muscle’s glucose-disposal capacity. Most importantly, total muscle mass matters more than fiber type alone, making resistance training a powerful tool for protecting metabolic health. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:02 — Introduction: Muscle Fibers and Diabetes Risk 02:07 — The Two Main Muscle Fiber Types 04:14 — Type 1 vs Type 2: Metabolic Differences 07:24 — Why Muscle Matters Most for Glucose Disposal 08:27 — Why Type 1 Fibers Support Better Insulin Sensitivity 11:56 — Fiber Type and Insulin Sensitivity in Healthy People 14:17 — How Lower Type 1 Fiber Proportion Predicts Risk 17:27 — Why More Muscle Matters More Than Fiber Conversion 20:41 — Ethnic Differences in Diabetes Risk 22:43 — Black Populations: More Type 2 Fibers and Higher Risk 25:02 — South Asians and the Thin-Fat Phenotype 27:33 — East Asians, Lower Muscle Mass, and BMI Limitations 28:36 — Native Americans and Extreme Diabetes Risk 31:01 — Pacific Islanders: High Muscle Mass, High Diabetes Risk 32:40 — Final Takeaways: Fiber Type Is Not Destiny NOTE: The…

    Not rated yet
  • Not rated yet
  • 145: Why GLP-1 Drugs Don’t Fix High Insulin

    · 34 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: GLP-1 is often described as an insulin-stimulating hormone, but in real meal settings its main role is to slow gastric emptying and reduce the need for insulin. Chronic hyperinsulinemia may progressively silence the gut’s GLP-1-producing L-cells, creating a vicious cycle in which high insulin lowers GLP-1, and low GLP-1 drives even higher insulin. Summary: GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time. Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1? Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time. The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:01 — Introduction: The Overlooked Crosstalk Between Insulin and GLP-1 03:25 — What GLP-1 Does and Why It Matters 07:01 — Does GLP-1 Really Stimulate Insulin? 10:36 — GLP-1 as an Insulin-Sparing Hormone 11:43 — The Bigger Question: Does Insulin Affect GLP-1? 12:48 — Human Evidence: Less GLP-1 in Insulin Resistance and Diabetes 17:31 — The Carb-Specific GLP-1 Blunting Pattern 18:49 — The L-Cell Has an Insulin Receptor 19:57 — Chronic High Insulin Makes L-Cells Insulin Resistant 23:18 — Why Hyperinsulinemia May Silence GLP-1 28:07 — Why GLP-1 Drugs Work Without Fixing the Root Cause 32:41 — The Vicious Cycle: High Insulin, Low GLP-1, More Overeating NOTE: The information presented is not intended to be a…

    Not rated yet
  • 144: Why Creatine Is One of the Most Important Brain Nutrients

    · 31 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Creatine supports brain function by rapidly regenerating ATP, making it essential for cognitive performance, especially under conditions of stress or low baseline levels. Clinical evidence shows it can improve memory, attention, mood, and resilience—particularly in vegetarians, older adults, women, and sleep-deprived individuals. Summary: Creatine is widely known as a muscle-building supplement, but in this lecture, Dr. Ben Bikman reveals its far more important and underappreciated role in brain function. Creatine acts as a rapid energy buffer through the phosphocreatine system, allowing brain cells to regenerate ATP within milliseconds during periods of high demand. Because the brain has extremely high energy needs and limited energy storage, this system is critical for maintaining cognitive performance, neurotransmitter signaling, and overall brain health. Dr. Bikman walks through the human clinical evidence showing that creatine supplementation can meaningfully improve cognitive function, particularly in individuals with lower baseline creatine levels or increased metabolic stress. These groups include vegetarians and vegans, older adults, and women—each of whom tend to have lower creatine availability or higher demand. Studies show improvements in memory, intelligence, attention, and executive function, especially when the brain is under strain, such as during sleep deprivation. The lecture also explores emerging research linking creatine to depression, traumatic brain injury, and neurodevelopmental disorders. In multiple randomized trials, creatine supplementation enhanced antidepressant responses, improved brain energy metabolism, and reduced cognitive impairment following sleep loss or injury. The overall message is clear: creatine is not just a performance supplement—it is a critical molecule for brain energy, cognition, and resilience under stress. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:03 — Introduction: Creatine Beyond Muscle 02:07 — How the Body Makes and Uses Creatine 03:03 — Dietary Creatine and Why Vegans May Be Deficient 04:06 — Why the Brain Needs Rapid Energy 05:22 — The Phosphocreatine System Explained 07:20 — Does Creatine Reach the Brain? 09:30 — Who Benefits Most from Creatine 10:31 — Vegetarians: Memory and Intelligence Improvements 12:45 — Sex Differences: Why Women Benefit More 15:57 — Creatine and Sleep Deprivation 20:21 — Creatine and Depression 25:13 — Creatine and Traumatic Brain Injury 30:48 — Final Takeaways Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with…

    Not rated yet
  • 143: Why Gum Disease Raises Your Blood Sugar

    · 33 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Gum disease allows oral bacteria and inflammatory signals to enter the bloodstream, driving systemic inflammation that disrupts insulin signaling and increases the risk of diabetes and cardiovascular disease. Because this relationship is bidirectional, improving oral health can meaningfully improve metabolic health and glycemic control. Summary: Most people think of gum disease as a local dental issue, but this lecture reveals a much broader and more consequential reality. Dr. Ben Bikman explains how the mouth serves as a gateway to systemic inflammation, particularly when periodontal disease allows bacteria and their toxic byproducts to enter the bloodstream. Once this happens, oral pathogens—especially P. gingivalis—can drive chronic inflammation, disrupt mitochondrial function, and contribute directly to insulin resistance. At the mechanistic level, Dr. Bikman outlines several pathways linking oral health to metabolic dysfunction. These include cytokine spillover (where inflammatory signals interfere with insulin signaling), direct degradation of insulin receptors by bacterial enzymes, dysregulation of liver glucose metabolism, and disruption of the gut microbiome. Together, these effects create a persistent inflammatory state that impairs glucose control and increases the risk of type 2 diabetes—even in individuals without obesity. The lecture also explores the strong epidemiological evidence supporting this connection, including studies showing that treating periodontal disease can significantly improve blood sugar control. Dr. Bikman further connects oral health to cardiovascular disease, highlighting how oral bacteria and endotoxins contribute to atherosclerosis. The takeaway is clear: oral health is not separate from metabolic health—it is a critical and often overlooked component of it. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:45 — Introduction: Why Oral Health Matters for Metabolism 01:43 — The Mouth as a Gateway to Systemic Inflammation 02:50 — The Oral Microbiome and Gum Disease Progression 03:51 — How Bacteria Enter the Bloodstream 05:02 — P. gingivalis and LPS: A Potent Inflammatory Trigger 07:45 — Chronic Inflammation and Insulin Resistance 08:54 — Mitochondrial Dysfunction from Oral Pathogens 10:08 — Cytokine Spillover and Insulin Signaling Disruption 13:37 — Liver Dysfunction and Glucose Overproduction 16:16 — Treating Periodontitis Improves Blood Sugar 21:01 — The Vicious Cycle Between Diabetes and Gum Disease 23:15 — Oral Bacteria and Cardiovascular Disease 29:11 — Practical Takeaways for Improving Oral Health NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and,…

    Not rated yet
  • 142: Ivermectin Explained - The Science Behind the Controversy with Dr. Ben Bikman

    · 29 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease. Summary: Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology. A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling, and can ultimately trigger apoptosis in cancer cells. Notably, these effects appear to be selective, with cancer cells showing greater sensitivity than healthy cells. Additional mechanisms—including inhibition of PAK1 and synergy with existing chemotherapy agents—further support ivermectin’s potential as a therapeutic candidate in oncology. Beyond cancer, ivermectin demonstrates meaningful metabolic effects. It reduces inflammation through suppression of NF-kappaB, activates AMPK, and influences glucose metabolism via FXR signaling. Preclinical studies show improvements in insulin sensitivity, glucose control, liver health, and even adipocyte behavior. While human data is still limited, Dr. Bikman emphasizes that the mechanistic consistency across pathways warrants serious clinical investigation rather than dismissal. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:15 — Introduction: The Science Behind Ivermectin 03:43 — Human Use vs “Horse Dewormer” Narrative 06:06 — Why Ivermectin Is Selective and Safe 08:13 — Mitochondria and Complex I Inhibition 10:37 — Selective Effects on Cancer Cells 11:45 — AMPK Activation and mTOR Suppression 15:52 — Anti-Inflammatory Effects via NF-kappaB 18:32 — FXR Activation and Glucose Metabolism 21:28 — Effects on Fat Cells and Adipogenesis 28:26 — Final Summary and Takeaways NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Ivermectin #MetabolicHealth #Mitochondria #CancerMetabolism #AMPK #mTOR #Inflammation…

    Not rated yet
  • 141: How Sleep Loss Rewires Your Hunger Hormones with Dr. Ben Bikman

    · 22 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Sleep loss alters key hunger hormones—reducing leptin and increasing ghrelin—while simultaneously activating reward pathways that increase cravings for calorie-dense foods. Because sleep and appetite hormones influence each other in both directions, improving sleep quality may be one of the most powerful tools for regulating hunger and metabolic health. Summary: Sleep is often treated as a simple lifestyle choice, but in reality it is one of the most powerful regulators of appetite and metabolic health. In this lecture, Dr. Ben Bikman explains the intricate hormonal relationship between sleep and hunger, highlighting how even short periods of sleep deprivation can dramatically alter the body’s appetite signals. Key hormones such as leptin and ghrelin shift in opposite directions during sleep restriction—satiety signaling declines while hunger signaling increases—creating a biological drive to eat more food. Ben also explores how sleep deprivation affects additional systems involved in appetite regulation, including the endocannabinoid system, cortisol rhythms, and the brain’s orexin neurons. These changes don’t just increase hunger—they specifically increase cravings for energy-dense, rewarding foods like chips, sweets, and other highly palatable options. Together, these hormonal changes create what researchers describe as an “obesogenic environment,” where the body becomes biologically primed to overeat. Importantly, the relationship works both ways. Hormones such as leptin and ghrelin also influence sleep quality, while melatonin plays a coordinating role in regulating the entire circadian system. Dr. Bikman concludes by emphasizing that optimizing sleep—especially protecting early-night deep sleep and minimizing artificial light at night—may be one of the most effective interventions for regulating appetite and improving metabolic health. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:59 — The Hidden Connection Between Sleep and Hunger 02:07 — Leptin vs Ghrelin: The Two Main Appetite Hormones 03:17 — What Happens to Hunger Hormones When You Don’t Sleep 04:26 — Evidence from the Wisconsin Sleep Cohort 05:42 — Meta-analysis Findings on Sleep and Appetite Hormones 06:59 — The Endocannabinoid System and Food Cravings 08:10 — Sleep Deprivation and Increased Snack Consumption 09:20 — Orexin and Sleep-Driven Appetite Signaling 09:47 — Cortisol Disruption from Poor Sleep 10:55 — Sleep Loss and Reduced Insulin Sensitivity 13:37 — Melatonin and Appetite Regulation 15:03 — Circadian Rhythm and Hormonal Coordination 16:19 — How Leptin Influences Sleep Quality 17:30 — Ghrelin, Wakefulness, and Insomnia 18:42 — Summary of the Sleep-Hunger Hormone Cascade 20:00 — Why Sleep Should Be Treated as a Metabolic…

    Not rated yet
  • 140: Why Alzheimer’s May Be a Metabolic Disease

    · 30 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Alzheimer’s disease has traditionally been explained by the buildup of amyloid plaques in the brain, but growing evidence suggests this theory does not fully account for the disease or lead to effective treatments. A metabolic perspective proposes that Alzheimer’s may instead be driven by brain insulin resistance, which disrupts neuronal energy metabolism—while the brain’s ability to use ketones as an alternative fuel remains intact, offering potential strategies for prevention and support. Summary: For decades, Alzheimer’s disease has largely been understood through the lens of the amyloid plaque hypothesis, which proposes that sticky protein deposits in the brain trigger neurodegeneration and cognitive decline. In this Metabolic Classroom lecture, Ben explains why that theory is increasingly being questioned. He reviews the historical origins of the plaque hypothesis and the repeated failure of drugs designed to remove amyloid plaques to meaningfully improve patient outcomes. The controversy surrounding manipulated data in influential Alzheimer’s research further highlights the need for a new framework to better explain the disease. Ben then presents a compelling alternative: Alzheimer’s disease as a metabolic disorder driven by brain insulin resistance. Drawing from mechanistic studies, epidemiological data, and genetic insights, he explains how impaired insulin signaling in the brain can disrupt neuronal energy metabolism, increase tau tangles, impair amyloid clearance, and ultimately contribute to neurodegeneration. This concept has led some researchers to refer to Alzheimer’s as “Type 3 diabetes.” The lecture also explores a hopeful implication of this metabolic framework. While glucose metabolism is impaired in Alzheimer’s brains, research shows that the brain’s ability to use ketones remains intact. This suggests that strategies that improve insulin sensitivity or increase ketone availability—such as carbohydrate restriction, fasting, exercise, or exogenous ketones—may offer promising avenues for prevention or metabolic support. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:15 — Why Alzheimer’s May Be a Metabolic Disease 02:18 — The Discovery of Alzheimer’s Disease 03:39 — The Amyloid Cascade Hypothesis 04:59 — The Plaque Problem: Why the Theory Doesn’t Fit 05:57 — The Retracted Alzheimer’s Paper Scandal 09:56 — The Brain Insulin Resistance Hypothesis 12:22 — Why Insulin Is Critical for Brain Function 14:13 — Diabetes and Alzheimer’s Risk 16:38 — The APOE4 Gene and Insulin Signaling 20:20 — Ketones as an Alternative Brain Fuel 23:57 — Evidence the Alzheimer’s Brain Can Still Use Ketones 27:21 — Ketones as a Potential Therapeutic Strategy 28:29 — Practical Strategies to Reduce…

    Not rated yet
  • 139: Why Some Thin People Get Diabetes and Ethnicity’s Impact with Dr. Ben Bikman

    · 41 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Metabolic disease is driven more by fat cell size and adipose tissue dysfunction than by total body fat. Ethnicity, genetics, and personal fat storage capacity determine when fat becomes metabolically dangerous. Summary: Dr. Bikman explores a profound but underappreciated truth in metabolic health: it is not how much fat you have that determines disease risk — it is how your fat is stored and how large your fat cells become. Using the metabolic paradox between the United States and Singapore as a starting point, Dr. Bikman explains why populations with dramatically different obesity rates can have nearly identical rates of type 2 diabetes. The key insight is that fat mass alone does not determine metabolic health. Instead, the size of individual fat cells and the body’s capacity to safely expand subcutaneous fat storage — what’s called the adipose expandability hypothesis — determines whether fat becomes harmful. White adipose tissue can expand in two ways: hypertrophy or hyperplasia. Hypertrophic fat cells become insulin resistant, release excessive free fatty acids even in the presence of insulin, promote ectopic fat deposition in the liver, and trigger chronic inflammation through hypoxia and HIF-1α signaling. This cascade drives fatty liver disease, systemic insulin resistance, and eventually type 2 diabetes. By contrast, hyperplastic expansion allows fat to be stored safely in small, metabolically healthy fat cells with normal vascularity and hormone signaling. This distinction explains why some individuals can carry more total fat yet remain metabolically healthy. Next is the concept of a personal fat threshold, largely influenced by genetics and ethnicity. South and East Asian populations tend to have a lower threshold for safe subcutaneous fat storage, meaning metabolic dysfunction can occur at lower BMIs compared to Europeans or Africans. This makes universal BMI cutoffs inadequate for assessing risk across ethnic groups. Finally, he discusses two more academic but mechanistically precise markers of fat cell health: the adiponectin-to-leptin ratio and the Adipo-IR index (fasting insulin × fasting free fatty acids). The takeaway: metabolic risk is determined by fat cell biology, not simply fat mass. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:00 — The U.S.–Singapore Metabolic Paradox 04:22 — Hypertrophy vs. Hyperplasia: Why Fat Cell Size Matters 07:52 — Insulin’s Anti-Lipolytic Role & Free Fatty Acids 10:04 — When High Insulin and High FFAs Coexist 12:19 — Ectopic Fat, Fatty Liver & the Diabetes Cascade 15:21 — Hypoxia, HIF-1α & Inflammatory Fat Cells 21:15 — The Adipose Expandability Hypothesis 25:40 — The Personal Fat Threshold Explained 32:06 — Why Universal BMI Cutoffs Fail…

    Not rated yet
  • 138: How Bile Controls Insulin, GLP-1, and Fat Burning with Dr. Ben Bikman

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Bile acids are powerful hormone-like signaling molecules that regulate liver fat, glucose production, insulin sensitivity, energy expenditure, inflammation, and GLP-1 release through FXR and TGR5 receptors. Gallbladder function and bile acid signaling play a far greater role in metabolic health than most people realize. Summary: Ben explores a largely overlooked metabolic regulator: bile acids. While bile is commonly understood as a digestive fluid that helps emulsify fats, bile acids are now recognized as powerful hormone-like signaling molecules that influence insulin sensitivity, mitochondrial function, thyroid hormone activation, inflammation, GLP-1 release, and fat cell behavior. Dr. Bikman explains the remarkable efficiency of enterohepatic circulation, where bile acids are reabsorbed and recycled multiple times per day. This recycling process allows bile acids to interact with key receptors — FXR (a nuclear receptor) and TGR5 (a G-protein coupled receptor) — triggering metabolic effects throughout the body. Activation of FXR reduces liver fat production, improves hepatic insulin sensitivity, lowers glucose output, and stimulates FGF19, which further suppresses excess glucose production. TGR5 activation increases energy expenditure via thyroid hormone activation in brown fat and muscle, stimulates GLP-1 release in the intestine, reduces inflammation in immune cells, and supports healthier adipose tissue signaling. Ben also examines the metabolic consequences of gallbladder removal. Without the gallbladder’s concentrated, timed bile release, signaling patterns change, and epidemiological data suggest increased risk of metabolic syndrome and fatty liver. Finally, Dr. Bikman discusses bile supplements such as ox bile and TUDCA, reviewing mechanistic rationale and human data showing improved insulin sensitivity in certain contexts. The overarching message: bile acids are not merely digestive detergents — they are among the most important and underappreciated metabolic signaling molecules in the body. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:00 — Bile: More Than a Digestive Fluid 03:05 — Bile Acid Synthesis from Cholesterol 04:10 — Gallbladder Storage and Fat Digestion 06:23 — Bile Acids as Signaling Molecules 07:28 — FXR and Liver Fat Reduction 08:27 — FGF19 and Glucose Regulation 09:31 — TGR5 and Thyroid Activation 10:38 — GLP-1 Stimulation by Bile Acids 11:34 — Anti-Inflammatory Effects via TGR5 12:56 — Bile Acids and Adipose Tissue Function 14:03 — Mitochondrial Biogenesis and Energy Expenditure 15:23 — Bile Acid Sequestrants and Glucose Control 16:26 — Gallbladder Removal and Metabolic Risk 18:40 — Ox Bile vs. TUDCA Supplements 19:49 — Human Trial: TUDCA and Insulin Sensitivity…

    Not rated yet
  • 137: LDL Isn’t the Problem? The Real Drivers of Heart Disease

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: LDL cholesterol is a weak predictor of heart disease compared to markers of insulin resistance, metabolic syndrome, and the triglyceride-to-HDL ratio. True cardiovascular risk is driven far more by metabolic dysfunction than by cholesterol numbers alone. Summary: In this episode, Ben challenges the long-standing belief that LDL cholesterol is the primary driver of heart disease. While LDL has dominated cardiovascular conversations for decades, large-scale data show that nearly half of people hospitalized with heart disease have “normal” LDL levels. Instead, the strongest predictors of cardiovascular risk — especially premature heart disease — are markers of metabolic dysfunction, particularly insulin resistance. Measures like the lipoprotein insulin resistance (LP-IR) score, type 2 diabetes status, metabolic syndrome, and even the simple triglyceride-to-HDL ratio dramatically outperform LDL cholesterol in predicting who will develop heart disease. One of the most practical tools discussed is the triglyceride-to-HDL ratio, which can be calculated from a standard lipid panel. This ratio reflects underlying insulin resistance and small, dense LDL particles far better than LDL levels alone. Dr. Bikman also reviews the modest benefits of statins in primary prevention and highlights a critical point: lowering LDL does not address the root metabolic dysfunction driving cardiovascular disease. In fact, statin use — particularly in women — may increase the risk of developing type 2 diabetes. The takeaway is clear: cardiovascular prevention should shift from being LDL-centric to metabolism-centric. Insulin sensitivity, triglycerides, HDL, fasting insulin, and glycemic control are far more powerful indicators of risk than LDL cholesterol alone. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:55 — Rethinking the LDL Narrative 02:05 — Massive Study: Heart Attacks with Normal LDL 03:14 — Why LDL Looks Weak Compared to Metabolic Markers 04:27 — Lipoprotein Insulin Resistance (LP-IR) Score Explained 05:38 — Diabetes, Metabolic Syndrome & Premature Heart Disease 06:52 — Introducing the Triglyceride-to-HDL Ratio 07:46 — Identifying Insulin Resistance from a Standard Lipid Panel 08:55 — Ratio Cutoffs & What They Mean 09:58 — The Copenhagen Male Study 11:03 — Same LDL, Very Different Risk 12:02 — Threefold Differences in Heart Disease Incidence 13:08 — Why LDL Alone Tells You Almost Nothing 14:18 — Evidence Across Populations 15:25 — Sex Differences in Cardiovascular Risk 16:39 — Statins & Primary Prevention Data 17:43 — The Modest Impact of LDL Lowering 18:45 — Statins & Increased Diabetes Risk 19:52 — Shifting from LDL-Centric to Metabolism-Centric 21:06 — HDL as a Metabolic Marker 22:22 — The Profound…

    Not rated yet
  • 136: Why Exercise Benefits Every Organ — Not Just Muscle — with Dr. Ben Bikman

    · 26 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Exercise prompts your muscles to release extracellular vesicles — tiny molecular packages that deliver health-boosting instructions to your brain, liver, fat, and more. These signals improve metabolism, reduce inflammation, and may even help reverse insulin resistance and obesity-related damage. Summary: Dr. Ben Bikman explains how extracellular vesicles (ECVs) — tiny biological packages released by cells — are revolutionizing our understanding of how exercise improves metabolic health. These vesicles act like molecular mail, delivering proteins, lipids, and microRNAs from one tissue to another, with effects that include improved insulin sensitivity, enhanced fat burning, and reduced inflammation. When we exercise, our muscles and other tissues release more ECVs, which travel throughout the body delivering beneficial molecular signals to organs like the liver, brain, fat cells, and immune system. Different types of exercise (aerobic vs. resistance) and different intensities produce ECVs with distinct “cargo,” which helps explain the diverse benefits of various workout styles. In conditions like obesity and type 2 diabetes, however, the story shifts. Dysfunctional tissues release harmful ECVs that can spread metabolic disease. Fortunately, exercise helps reverse this, replacing harmful signals with beneficial ones. Even brief bouts of exercise can shift this internal “conversation” in a healthier direction. Ben closes by highlighting the future potential of ECV research: personalized exercise prescriptions, new biomarkers, and even therapeutic applications like “exercise in a bottle.” But until then, the takeaway is clear: exercise isn’t just about movement — it’s a system-wide signal for better health. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:00 — What Are Extracellular Vesicles? 02:10 — How Exercise Affects ECVs 04:24 — Types of ECVs and How They Deliver Cargo 05:31 — Muscle-to-Liver Communication via ECVs 06:49 — Quality vs. Quantity of Vesicle Cargo 08:03 — Different Exercises, Different ECVs 09:20 — Muscle Sharing Metabolic Fitness 10:32 — Brain-Body Communication 11:53 — ECVs and Insulin Sensitivity 13:14 — Fat Browning and Thermogenesis 14:28 — Anti-Inflammatory Effects 15:47 — The Dark Side of ECVs in Obesity 16:59 — Type 2 Diabetes and Liver-Derived ECVs 19:25 — The Hopeful Reversal: Exercise as ECV Therapy 21:35 — Practical Tips & Daily Exercise 22:38 — Future Possibilities: Biomarkers & Engineered Vesicles 25:04 — Final Takeaway NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with…

    Not rated yet
  • 135: How Glucose Overload Breaks Your Metabolism (And How to Fix It) with Dr. Ben Bikman

    · 27 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: This episode explores how the NAD⁺/NADH ratio acts as a key metabolic switch, where excess NADH—often driven by high glucose intake—leads to insulin resistance and cellular dysfunction. Ben highlights how lifestyle changes, not supplements, offer the most effective way to restore balance and protect metabolic health. Summary: In this mini lecture, Dr. Bikman explains the critical role of the NAD⁺ to NADH ratio in cellular metabolism and its link to insulin resistance. NAD⁺ and NADH function like a cellular battery, cycling between charged and uncharged states to fuel energy production. However, when this balance tips toward excess NADH—as happens with chronic high glucose intake, aging, alcohol consumption, or inactivity—metabolic dysfunction follows. Ben walks through the mechanisms by which a low NAD⁺/NADH ratio disrupts insulin signaling, including suppression of mitochondrial function, accumulation of harmful lipid intermediates (like ceramides), and increased oxidative stress. He also introduces the concept of "reductive stress," a pseudo-hypoxic state that cells enter when overwhelmed by glucose, leading to long-term damage and perpetuation of insulin resistance. To improve this ratio and support better metabolic health, Dr. Bikman recommends five main lifestyle strategies: restricting refined carbohydrates, exercising regularly, practicing time-restricted eating, optimizing sleep, and reducing or eliminating alcohol. While NAD⁺-boosting supplements like nicotinamide riboside show promise in animal models, their human effects remain limited—highlighting that lifestyle changes still provide the most reliable path to metabolic improvement. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:55 — What NAD⁺/NADH Does in the Cell 02:08 — The Ratio as a Metabolic Indicator 03:33 — Overnutrition and Mitochondrial Overload 05:40 — Ceramides, Sirtuins, and Metabolic Dysfunction 06:44 — The Hexosamine Pathway and Protein Modification 07:54 — Pseudo-Hypoxia from Chronic Hyperglycemia 09:59 — The Polyol Pathway and Reductive Stress 11:13 — Glycolysis Backup and Further Damage 12:24 — Mitochondrial Overload → Superoxide → Insulin Resistance 13:26 — Dietary Carbs and NAD⁺ Depletion 14:35 — Aging, Alcohol, and Sedentary Living 15:43 — Five Lifestyle Fixes: Diet, Exercise, Fasting, Sleep, Alcohol 18:16 — NAD⁺ Supplements: Mechanisms and Hype 20:28 — Human Trials: What the Evidence Says 22:32 — Dosing, Bioavailability, and Industry Caution 24:38 — Summary: NAD⁺ Strategies That Actually Work NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own…

    Not rated yet
  • 134: Why Your Cells Age (And What You Can Do About It) with Dr. Ben Bikman

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Ben explains how AMPK and mTOR are critical regulators of aging and metabolism, and how their balance can be influenced by diet and lifestyle. Instead of drugs like rapamycin, strategies like carbohydrate restriction and ketosis offer a safer path to optimizing longevity. Summary: In this Metabolic Classroom mini lecture, Dr. Bikman explores two of the most important molecular “switches” that regulate how cells age, grow, and repair themselves: AMPK and mTOR. These pathways operate in a delicate balance—AMPK promotes energy conservation, fat oxidation, and cellular cleanup (autophagy), while mTOR supports cellular growth and protein synthesis. When AMPK is up, mTOR is down, and vice versa. Ben explains how modern lifestyles—especially chronic overnutrition and excess carbohydrate intake—shift this balance toward persistent mTOR activation, which may accelerate aging and metabolic disease. He critiques the growing popularity of rapamycin for longevity, citing its lack of human data and serious side effects, particularly reproductive harm. Instead, he proposes that simple lifestyle strategies—like carbohydrate restriction, ketosis, and supplementation with ketones like BHB—can more safely optimize the AMPK/mTOR balance. He also highlights the importance of ketones as both energy sources and signaling molecules that can activate AMPK and stimulate autophagy. The lecture ends with a clear takeaway: longevity and metabolic health may not require pharmaceuticals, but rather informed choices around diet and lifestyle. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:00 — Intro: The Two Master Switches of Aging 02:12 — AMPK: The Energy Sensor and Fat-Burner 04:00 — How AMPK Promotes Autophagy and Longevity 05:32 — What Happens When AMPK Declines 07:15 — mTOR: The Growth Pathway and Its Role in Aging 09:10 — Finding the Balance Between AMPK and mTOR 11:02 — Rapamycin: Extending Lifespan in Mice (But at What Cost?) 13:00 — Side Effects and Human Considerations 14:30 — Protein Restriction vs. Insulin for Longevity 16:20 — Carbs as the True Driver of mTOR Activation 18:10 — Metformin and Other AMPK Activators 20:05 — Ketones: Nature’s Longevity Molecule 22:00 — Summary: Let Food Be Your Signal 23:15 — Final Thoughts: Aging Smarter, Not Just Slower NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #AMPK #mTOR #Longevity #Autophagy #Ketones #MetabolicHealth #AntiAging #IntermittentFasting #LowCarbLife #CellularRepair #KetogenicLiving #RapamycinRisks…

    Not rated yet
  • 133: Separating Nicotine from Smoking - Myths, Metabolism, and Medicine with Dr. Ben Bikman

    · 22 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com Topic: Nicotine may not be the addictive villain it's made out to be. When separated from cigarette smoke, it shows surprising anti-inflammatory and neurological potential. Summary: In this Metabolic Classroom mini lecture, Dr. Ben Bikman revisits the molecule nicotine—not as an endorsement to use it, but to explore its distinct effects when separated from harmful compounds in cigarettes. Contrary to popular belief, nicotine alone is not highly addictive; tobacco additives like pyrazines likely amplify the addiction seen in cigarettes. Dr. Bikman details nicotine’s anti-inflammatory properties, particularly through activation of the alpha-7 nicotinic acetylcholine receptor, which may help conditions like ulcerative colitis, sepsis, and arthritis. Ben also explores its complex effects on metabolism—such as increased thermogenesis and fat oxidation—while warning of potential insulin resistance with sustained use. Lastly, he reviews fascinating clinical research suggesting therapeutic potential in conditions like ADHD, autism, Tourette’s syndrome, and even Alzheimer’s, all while emphasizing that nicotine, when separated from cigarette smoke, warrants more open scientific inquiry. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and online, live Office Hours access with Ben. It also includes Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 1:20 - Introduction: A different look at nicotine 2:25 - Is nicotine really addictive on its own? 4:12 - Pyrazines and tobacco industry engineering 5:25 - The real reason cigarettes are so addictive 6:29 - The cholinergic anti-inflammatory pathway 7:45 - Nicotine as an immunomodulator 8:57 - Nicotine’s effects on fat metabolism and appetite 10:02 - Nicotine can also promote insulin resistance 11:19 - Nicotine and ADHD treatment studies 12:39 - Autism, aggression, and nicotine research 13:46 - Tourette’s syndrome and reduced symptoms with nicotine 14:57 - Nicotine’s potential in Alzheimer’s and cognitive decline 17:32 - Nicotine and ulcerative colitis 18:57 - Delivery methods: patches, gum, pouches 21:04 - Reframing nicotine’s reputation 22:10 - Final thoughts: therapeutic potential vs. public fear NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #nicotine #smokingmyths #metabolichealth #insulinresistance #adhd #autism #tourettessyndrome #alzheimers #cognitivedecline #inflammation #cholinergicpathway #fatburning #weightloss #thermogenesis #lipolysis #ulcerativecolitis #nicotinepatch #mentalhealth #brainhealth #benbikman Ben’s favorite yerba mate and fiber:…

    Not rated yet
  • 132: The Hidden Power of Ketones: Fueling + Signaling with Dr. Ben Bikman

    · 28 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com Topic: Ketones, particularly BHB, aren’t just backup fuel—they’re powerful signals that affect inflammation, gene expression, and mitochondrial function. This episode shows how BHB acts like a hormone to enhance metabolic health and cellular resilience. Summary: In this episode of the Metabolic Classroom, Dr. Bikman explores the remarkable role of beta-hydroxybutyrate (BHB), the most abundant ketone body, as both a metabolic fuel and a cellular signaling molecule. While traditionally seen as mere backup energy, BHB is now recognized as a potent agent that influences gene expression, reduces inflammation, and protects mitochondrial function. Ben unpacks the dual nature of BHB, describing how it activates specific receptors like GPR109A and FFAR3, modulates immune responses, and directly inhibits the NLRP3 inflammasome, a key player in chronic inflammation. He also highlights how BHB affects epigenetic regulation through HDAC inhibition, enhancing cellular resilience and antioxidant defenses. The lecture concludes by tying these pathways together to show how ketones—whether produced endogenously or taken as supplements—convey a coordinated biological signal of adaptation and protection. This shift in understanding elevates ketones from mere “backup fuel” to central players in metabolic health. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and online, live Office Hours access with Ben. It also includes Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:20 — Introduction: Ketones as Fuel and Signals 02:03 — Structure and Types of BHB 03:15 — Ketone Production and Circulation 04:45 — How BHB Is Metabolized 05:55 — BHB’s First Receptor: GPR109A 08:45 — GPR109A and Inflammation 10:23 — BHB’s Role in the Brain and Stroke 11:45 — Second Receptor: FFAR3 and Sympathetic Nervous System 12:55 — BHB and Cancer via FFAR3 14:00 — BHB and the NLRP3 Inflammasome 16:05 — BHB’s Mechanism of Inflammation Inhibition 17:25 — NLRP3 in Disease: Alzheimer’s, Gout, etc. 18:45 — BHB as an Epigenetic Modifier 20:45 — FOX03A, MT2, and Antioxidant Gene Expression 22:35 — Summary: BHB’s Mitochondrial and Anti-Inflammatory Benefits 24:15 — BHB in Clinical Application and Therapeutics 25:55 — Final Takeaway: BHB as a Master Signal NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Ketones #BHB #MetabolicHealth #DrBenBikman #InsulinResistance #NLRP3 #Inflammation #Mitochondria #HDAC #NutritionalKetosis #KetogenicDiet #ExogenousKetones #Fasting #Autophagy #AlzheimersPrevention #Epigenetics #CellularHealth #BenBikman…

    Not rated yet
  • 131: GLP-1 Isn’t Enough - Why Glucagon is the Key to Lasting Weight Loss with Dr. Ben Bikman

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site, Insulin IQ: https://insuliniq.com In this lecture, Dr. Ben Bikman explores the misunderstood role of glucagon, insulin’s often-overlooked metabolic counterpart. While insulin encourages fat storage and glucose uptake, glucagon signals the body to mobilize and burn stored energy. Contrary to popular belief, glucagon does not stimulate fat release from adipose tissue in humans. Instead, its fat-burning effects occur primarily in the liver, where it enhances fatty acid oxidation, ketone production, and energy expenditure. Glucagon’s power lies in shifting the metabolic balance through the insulin-to-glucagon ratio—a key determinant of whether the body stores or burns fat. Ben also unpacks the liver's molecular response to glucagon, including activation of mitochondrial fat-burning enzymes and ketone formation. Human studies now confirm that glucagon increases liver fat oxidation, making it a valuable target in new weight-loss drugs. New dual and triple agonist drugs that combine GLP-1 with glucagon receptors show superior weight loss outcomes compared to GLP-1 alone. They not only suppress appetite but also increase metabolic rate, making them potent tools in fighting obesity and fatty liver disease. However, lifestyle strategies like fasting and low-carb diets remain powerful ways to naturally leverage glucagon’s benefits without pharmaceutical intervention. Show Notes/References: For complete show notes and references, we invite you to become an Insider subscriber or member. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and online, live Office Hours access with Ben. It also includes Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:22 — What Is Glucagon and How Does It Work? 03:07 — The Insulin-to-Glucagon Ratio Explained 04:42 — Glucagon's Role in Fasting and Ketosis 06:27 — Busting the Myth: Glucagon and Fat Cells 08:12 — Where Glucagon Really Burns Fat: The Liver 10:07 — Molecular Pathways of Glucagon in the Liver 12:22 — Glucagon and Ketone Production 14:07 — Why the Insulin-to-Glucagon Ratio Matters 15:52 — GLP-1 vs. Dual/Triple Agonist Weight Loss Drugs 17:37 — Clinical Trials: Sirduotide and Retatrutide Results 20:07 — Final Thoughts: How to Activate Glucagon Naturally NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Glucagon #FatBurning #InsulinResistance #LiverHealth #Ketones #GLP1 #Ozempic #WeightLossDrugs #FattyLiver #Metabolism #LowCarbDiet #FastingForFatLoss #HormoneHealth #MetabolicHealth #Type2Diabetes #KetoScience #GLP1Agonist #DualAgonist #WeightLossScience #BenBikman Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous ketones: A high-quality option is the…

    Not rated yet

More in Health

See all Health shows